apidra
sanofi-aventis deutschland gmbh - insulina glulisine - diabetes mellitus - drogi użati fid-dijabete - trattament ta 'adulti, adoloxxenti u tfal, ta' sitt snin jew aktar b'dijabete mellitus, fejn huwa meħtieġ it-trattament bl-insulina.
actraphane
novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.
mixtard
novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.
lyxumia
sanofi winthrop industrie - lixisenatide - diabetes mellitus, tip 2 - drugs used in diabetes, glucagon-like peptide-1 (glp-1) analogues - lyxumia is indicated for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with oral glucose lowering medicinal products and/or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control.
lusduna
merck sharp & dohme b.v. - insulina glargine - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus f'adulti, adolexxenti u tfal ta 'sentejn u aktar.
tresiba
novo nordisk a/s - insulina degludec - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus fl-adulti.
insulatard
novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.
ryzodeg
novo nordisk a/s - insulina aspart, l-insulina degludec - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus f'adulti, adolexxenti u tfal mill-età ta 'sentejn.
protaphane
novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.
actrapid
novo nordisk a/s - insulina umana - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.